Zev S. Scherl
Directeur Général chez MXY D, Inc.
Profil
Zev S.
Scherl is currently the Chief Executive Officer & Director at Mxy C, Inc., Chief Executive Officer & Director at MXY D, Inc., Director at AppTec Laboratory Services, Inc., Director at NB Therapeutics, and Director at Core Essence Orthopaedics, Inc. He is also the President & Chief Commercial Officer at AV Solutions LLC since 2014.
Mr. Scherl has formerly worked as a Director at Enterprises Holdings, Inc., EKR Therapeutics, Inc., Immune Control, Inc., and Vecta Ltd.
He has also worked as a Senior Director-Strategic Planning at Value Health, Inc., Investment Banker at Lehman Brothers, Inc., Manager-US Pricing Policy at Merck & Co., Inc., Portfolio Manager at FirstMark Capital LLC, and General Partner at NewSpring Healthcare.
Mr. Scherl has an undergraduate degree from Duke University and an MBA degree from Harvard Business School.
Postes actifs de Zev S. Scherl
| Sociétés | Poste | Début |
|---|---|---|
AppTec Laboratory Services, Inc.
 AppTec Laboratory Services, Inc. Miscellaneous Commercial ServicesCommercial Services AppTec Laboratory Services, Inc. provides testing services to the biopharmaceutical and medical device industries. The company's services include testing, contract R&D, cGMP manufacturing, tissue-based, combination products, and cellular therapeutics. The company was founded by Bonita L. Baskin in 1989 and is headquartered in St. Paul, MN. | Directeur/Membre du Conseil | - |
Core Essence Orthopaedics, Inc.
 Core Essence Orthopaedics, Inc. Medical SpecialtiesHealth Technology Core Essence Orthopaedics, Inc. develops and manufactures minimally invasive soft tissue and arthroscopic musculoskeletal surgical solutions. It offers knotless suture fixation systems, compression devices, suture anchor systems, and synchronized endoscopic guide systems for feet/ankles. The company was founded by Alan B. Miller, Shawn T. Huxel and Jeffrey B. Miller in 2007 and is headquartered in Fort Yardley, PA. | Directeur/Membre du Conseil | 18/07/2011 |
NB Therapeutics
 NB Therapeutics Pharmaceuticals: MajorHealth Technology NB Therapeutics, Inc. develops pharmacologic therapies. The firm has two technology platforms: iontophoresis and nitric oxide gas, through these two technology platforms it seeks to address the inherent challenges of drug delivery for diseases of the skin and nails. The company was founded by Frank J. McCaney in 2006 and is headquartered in Bristol, PA. | Directeur/Membre du Conseil | - |
AV Solutions LLC
 AV Solutions LLC Electronics/Appliance StoresRetail Trade AV Solutions LLC retails audio visual equipment. It offers broadcasts and webcasts, studios and on productions, video productions, and national wide audiovisual services. The company was founded by Doug Mack in 2005 and is headquartered in Fairfield, NJ. | President | 01/01/2014 |
MXY D, Inc.
 MXY D, Inc. Pharmaceuticals: OtherHealth Technology MXY D, Inc. is a pooled investment fund, which engages in the production of cannabis products. The company is headquartered in Long Beach, CA. | Directeur Général | - |
Mxy C, Inc.
 Mxy C, Inc. Pharmaceuticals: OtherHealth Technology Mxy C, Inc. produces and distributes cannabis products. The company is headquartered in Long Beach, CA. | Directeur Général | - |
Anciens postes connus de Zev S. Scherl
| Sociétés | Poste | Fin |
|---|---|---|
Immune Control, Inc.
 Immune Control, Inc. Pharmaceuticals: MajorHealth Technology Immune Control is an emerging pharmaceutical company developing novel, orally available, small molecules for autoimmune/inflammatory diseases. The company is commercializing the discovery that serotonin is a required growth factor for dividing lymphocytes. Certain serotonin antagonists eliminate activated or dividing T- or B-lymphocytes without disturbing resting lymphocytes. The ability to kill activated immune cells selectively has important implications for treating autoimmune/inflammatory diseases, hematologic cancers, and organ transplant rejection. Immune Control is a first-mover and the leader in the emerging field of serotonin-based immunotherapeutics. Their preclinical development program has yielded important insights into the design of orally available, potent, small molecules for autoimmune/inflammatory conditions. Immune Control is focused initially on two diseases: rheumatoid arthritis and asthma. Immune Control designs and develops novel compounds using in vitro and in vivo assays for receptor binding, efficacy, safety, and bioavailability. In 2008, the company plans to nominate two compounds as IND candidates for RA and asthma. In addition, they are conducting phase 1, proof-of-concept clinical trials in multiple myeloma and psoriasis, utilizing a currently approved serotonin antagonist. | Directeur/Membre du Conseil | 06/12/2012 |
EKR Therapeutics, Inc.
 EKR Therapeutics, Inc. Hospital/Nursing ManagementHealth Services EKR Therapeutics, Inc. is a specialty pharmaceutical company focused on acquiring, developing and maximizing the potential utility of critical-care hospital products offering broader therapeutic options and greater control to improve in-patient care, speed recovery, and achieve optimal outcomes. Backed by the strength of its award winning management team, the dedication of its field force of product specialists and its commitment to excellence in customer service and medical education, EKR has been organized to be a class leader in commercializing products to address unmet and under-satisfied medical needs or to otherwise enhance the therapeutic value of acute-care products. | Directeur/Membre du Conseil | 03/10/2012 |
Vecta Ltd.
 Vecta Ltd. Medical SpecialtiesHealth Technology Vecta Ltd. develops products for the gastrointestinal diseases. Its product VECAM-111 meets a well-known unmet need to address symptoms of gastroesophageal reflux disease (GERD) that are not commonly addressed by existing therapeutic options. The company develops enhanced novel drug formulation for symptomatic GERD. Vecta was founded by Yehuda Chowers and Dan J. Gelvan in 2001 and is headquartered in Ramat Gan, Israel. | Directeur/Membre du Conseil | - |
| ░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Zev S. Scherl
| Duke University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Entreprise privées | 14 |
|---|---|
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Finance |
AppTec Laboratory Services, Inc.
AppTec Laboratory Services, Inc. Miscellaneous Commercial ServicesCommercial Services AppTec Laboratory Services, Inc. provides testing services to the biopharmaceutical and medical device industries. The company's services include testing, contract R&D, cGMP manufacturing, tissue-based, combination products, and cellular therapeutics. The company was founded by Bonita L. Baskin in 1989 and is headquartered in St. Paul, MN. | Commercial Services |
Enterprises Holdings, Inc.
 Enterprises Holdings, Inc. Pharmaceuticals: OtherHealth Technology Enterprises Holdings, Inc. designs, manufactures, and markets products for the orthopedic sports medicine market. The company was founded by Mark A. Johanson on August 16, 2000 and is headquartered in Hazelwood, MO. | Health Technology |
EKR Therapeutics, Inc.
EKR Therapeutics, Inc. Hospital/Nursing ManagementHealth Services EKR Therapeutics, Inc. is a specialty pharmaceutical company focused on acquiring, developing and maximizing the potential utility of critical-care hospital products offering broader therapeutic options and greater control to improve in-patient care, speed recovery, and achieve optimal outcomes. Backed by the strength of its award winning management team, the dedication of its field force of product specialists and its commitment to excellence in customer service and medical education, EKR has been organized to be a class leader in commercializing products to address unmet and under-satisfied medical needs or to otherwise enhance the therapeutic value of acute-care products. | Health Services |
Value Health, Inc.
 Value Health, Inc. Managed Health CareHealth Services Value Health, Inc. was a provider of specialty care benefit programs to insurance carriers, corporations, managed care organizations and federal, state and local governments. The company's businesses included pharmacy benefit management; mental health and substance abuse management; workers' compensation, disability and group health management and disease management. The company was founded by Robert E. Patricelli and Steve Shulman and was located in Avon, CT. | Health Services |
FirstMark Capital LLC
 FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | Finance |
Immune Control, Inc.
Immune Control, Inc. Pharmaceuticals: MajorHealth Technology Immune Control is an emerging pharmaceutical company developing novel, orally available, small molecules for autoimmune/inflammatory diseases. The company is commercializing the discovery that serotonin is a required growth factor for dividing lymphocytes. Certain serotonin antagonists eliminate activated or dividing T- or B-lymphocytes without disturbing resting lymphocytes. The ability to kill activated immune cells selectively has important implications for treating autoimmune/inflammatory diseases, hematologic cancers, and organ transplant rejection. Immune Control is a first-mover and the leader in the emerging field of serotonin-based immunotherapeutics. Their preclinical development program has yielded important insights into the design of orally available, potent, small molecules for autoimmune/inflammatory conditions. Immune Control is focused initially on two diseases: rheumatoid arthritis and asthma. Immune Control designs and develops novel compounds using in vitro and in vivo assays for receptor binding, efficacy, safety, and bioavailability. In 2008, the company plans to nominate two compounds as IND candidates for RA and asthma. In addition, they are conducting phase 1, proof-of-concept clinical trials in multiple myeloma and psoriasis, utilizing a currently approved serotonin antagonist. | Health Technology |
NB Therapeutics
NB Therapeutics Pharmaceuticals: MajorHealth Technology NB Therapeutics, Inc. develops pharmacologic therapies. The firm has two technology platforms: iontophoresis and nitric oxide gas, through these two technology platforms it seeks to address the inherent challenges of drug delivery for diseases of the skin and nails. The company was founded by Frank J. McCaney in 2006 and is headquartered in Bristol, PA. | Health Technology |
NewSpring Healthcare
 NewSpring Healthcare Investment ManagersFinance NewSpring Healthcare is the venture capital/private equity operating health care division of NewSpring Capital LLC founded in 1999. The firm is headquartered in Radnor, Pennsylvania. | Finance |
Core Essence Orthopaedics, Inc.
Core Essence Orthopaedics, Inc. Medical SpecialtiesHealth Technology Core Essence Orthopaedics, Inc. develops and manufactures minimally invasive soft tissue and arthroscopic musculoskeletal surgical solutions. It offers knotless suture fixation systems, compression devices, suture anchor systems, and synchronized endoscopic guide systems for feet/ankles. The company was founded by Alan B. Miller, Shawn T. Huxel and Jeffrey B. Miller in 2007 and is headquartered in Fort Yardley, PA. | Health Technology |
Vecta Ltd.
Vecta Ltd. Medical SpecialtiesHealth Technology Vecta Ltd. develops products for the gastrointestinal diseases. Its product VECAM-111 meets a well-known unmet need to address symptoms of gastroesophageal reflux disease (GERD) that are not commonly addressed by existing therapeutic options. The company develops enhanced novel drug formulation for symptomatic GERD. Vecta was founded by Yehuda Chowers and Dan J. Gelvan in 2001 and is headquartered in Ramat Gan, Israel. | Health Technology |
AV Solutions LLC
AV Solutions LLC Electronics/Appliance StoresRetail Trade AV Solutions LLC retails audio visual equipment. It offers broadcasts and webcasts, studios and on productions, video productions, and national wide audiovisual services. The company was founded by Doug Mack in 2005 and is headquartered in Fairfield, NJ. | Retail Trade |
Mxy C, Inc.
Mxy C, Inc. Pharmaceuticals: OtherHealth Technology Mxy C, Inc. produces and distributes cannabis products. The company is headquartered in Long Beach, CA. | Health Technology |
MXY D, Inc.
MXY D, Inc. Pharmaceuticals: OtherHealth Technology MXY D, Inc. is a pooled investment fund, which engages in the production of cannabis products. The company is headquartered in Long Beach, CA. | Health Technology |
